Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 35 full-time employees. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Follow-Up Questions
What is Sensus Healthcare Inc (SRTS)'s P/E Ratio?
The P/E ratio of Sensus Healthcare Inc is 7.7538
Who is the CEO of Sensus Healthcare Inc?
Mr. Joseph Sardano is the Chairman of the Board of Sensus Healthcare Inc, joining the firm since 2010.
What is the price performance of SRTS stock?
The current price of SRTS is $3.11, it has increased 0.03% in the last trading day.
What are the primary business themes or industries for Sensus Healthcare Inc?
Sensus Healthcare Inc belongs to Health Care industry and the sector is Health Care
What is Sensus Healthcare Inc market cap?
Sensus Healthcare Inc's current market cap is $51.1M
Is Sensus Healthcare Inc a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for Sensus Healthcare Inc, including 2 strong buy, 8 buy, 1 hold, 0 sell, and 2 strong sell
